Pediatrix Medical (MD) Short-Term Debt issuances (2009 - 2024)

Pediatrix Medical (MD) has reported Short-Term Debt issuances for 15 consecutive years, with $65.0 million the latest figure, recorded in Q2 2024.

• On a quarterly basis, Short-Term Debt issuances fell 68.29% year-over-year to $65.0 million in Q2 2024; TTM through Mar 2025 was $65.0 million, a 84.83% decrease from a year earlier, with the FY2024 full-year figure at $235.5 million, down 50.32% from the prior year.
• Short-Term Debt issuances was $65.0 million for Q2 2024 at Pediatrix Medical, down from $170.5 million in the prior quarter.
• Over five years, Short-Term Debt issuances peaked at $515.0 million in Q1 2020 and troughed at $12.5 million in Q2 2020.
• A 4-year average of $187.9 million and a median of $199.5 million in 2022 frame the typical range for Short-Term Debt issuances.
• Across the five-year window, Short-Term Debt issuances tumbled 97.03% in 2020 and retreated 9.49% in 2023, its largest moves.
• Over 4 years, Short-Term Debt issuances stood at $12.5 million in 2020, then jumped by 1144.0% to $155.5 million in 2022, then sank by 65.92% to $53.0 million in 2023, then climbed by 22.64% to $65.0 million in 2024.
• The last three Short-Term Debt issuances figures came in at $65.0 million (Q2 2024), $170.5 million (Q1 2024), and $53.0 million (Q3 2023), per Business Quant data.